Treatment of COVID-19: A review of emerging treatment
dc.contributor.author | Wanigatunge, C.A. | |
dc.contributor.author | Munidasa, D. | |
dc.contributor.author | Uluwattage, W. | |
dc.contributor.author | Sathischandra, H. | |
dc.contributor.author | Rajapakse, S. | |
dc.date.accessioned | 2020-12-27T15:03:29Z | |
dc.date.available | 2020-12-27T15:03:29Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 51(1):p.36-42 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/25199 | |
dc.publisher | Ceylon College of Physicians:Rajagiriya | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.subject | Chloroquine | |
dc.subject | Hydroxychloroquine | |
dc.subject | Remdesivir | |
dc.subject | Favipiravir | |
dc.subject | Lopinavir-ritonavir | |
dc.title | Treatment of COVID-19: A review of emerging treatment | |
dc.type | Article |